CN1365388A - 用于基因转移的病毒包膜载体 - Google Patents
用于基因转移的病毒包膜载体 Download PDFInfo
- Publication number
- CN1365388A CN1365388A CN01800567A CN01800567A CN1365388A CN 1365388 A CN1365388 A CN 1365388A CN 01800567 A CN01800567 A CN 01800567A CN 01800567 A CN01800567 A CN 01800567A CN 1365388 A CN1365388 A CN 1365388A
- Authority
- CN
- China
- Prior art keywords
- gene transfer
- gene
- transfer vector
- virus
- hvj
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16661—Methods of inactivation or attenuation
- C12N2710/16663—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18823—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18861—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18861—Methods of inactivation or attenuation
- C12N2760/18863—Methods of inactivation or attenuation by chemical treatment
Abstract
Description
Claims (19)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25596/00 | 2000-02-02 | ||
JP2000025596 | 2000-02-02 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004101002195A Division CN100542614C (zh) | 2000-02-02 | 2001-02-02 | 用于基因转移的病毒包膜载体 |
CNA2008100016273A Division CN101302536A (zh) | 2000-02-02 | 2001-02-02 | 用于基因转移的病毒包膜载体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1365388A true CN1365388A (zh) | 2002-08-21 |
CN100532559C CN100532559C (zh) | 2009-08-26 |
Family
ID=18551433
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004101002195A Expired - Lifetime CN100542614C (zh) | 2000-02-02 | 2001-02-02 | 用于基因转移的病毒包膜载体 |
CNB018005675A Expired - Lifetime CN100532559C (zh) | 2000-02-02 | 2001-02-02 | 用于基因转移的病毒包膜载体 |
CNA2008100016273A Pending CN101302536A (zh) | 2000-02-02 | 2001-02-02 | 用于基因转移的病毒包膜载体 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004101002195A Expired - Lifetime CN100542614C (zh) | 2000-02-02 | 2001-02-02 | 用于基因转移的病毒包膜载体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100016273A Pending CN101302536A (zh) | 2000-02-02 | 2001-02-02 | 用于基因转移的病毒包膜载体 |
Country Status (10)
Country | Link |
---|---|
US (3) | US6913923B2 (zh) |
EP (1) | EP1170363B1 (zh) |
KR (2) | KR100776475B1 (zh) |
CN (3) | CN100542614C (zh) |
AU (1) | AU769385C (zh) |
CA (1) | CA2369491C (zh) |
DE (1) | DE60131498T8 (zh) |
HK (1) | HK1047449A1 (zh) |
TW (1) | TWI303663B (zh) |
WO (1) | WO2001057204A1 (zh) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU769385C (en) * | 2000-02-02 | 2004-07-29 | Genomldea Inc. | Virus envelope vector for gene transfer |
WO2002000264A1 (fr) * | 2000-06-27 | 2002-01-03 | Dnavec Research Inc. | Vecteur de virus pour transfert de gene dans des cellules renales |
EP1690544B1 (en) * | 2001-02-20 | 2017-09-13 | AnGes MG, Inc. | Pharmaceutical composition containing decoy and method of using the same |
WO2003014338A1 (fr) * | 2001-08-02 | 2003-02-20 | Anges Mg, Inc. | Procede de production d'enveloppes virales inactivees |
US20040265272A1 (en) * | 2001-09-28 | 2004-12-30 | Aikichi Iwamoto | Mammalian cell-infecting virus vector encoding epitope-bound beta2m and utilization thereof |
WO2003063911A1 (fr) | 2002-02-01 | 2003-08-07 | Anges Mg, Inc. | Compositions pharmaceutiques contenant un leurre et procede d'utilisation |
CA2490357A1 (en) * | 2002-06-06 | 2003-12-18 | Anges Mg, Inc. | Gene therapeutic for cerebrovascular disorders |
CA2497313A1 (en) * | 2002-08-27 | 2004-04-29 | Anges Mg, Inc. | Biomolecule transfer method using virus envelope and composition and system therefor |
JPWO2004031380A1 (ja) * | 2002-10-01 | 2006-02-02 | 株式会社ディナベック研究所 | TAP活性の阻害によりMHCclassIによる外来エピトープの提示を増強する方法 |
EP1568379A1 (en) * | 2002-11-01 | 2005-08-31 | Genomidea Inc | Medicinal preparation having chemotherapeutic encapsulated therein |
JPWO2004046353A1 (ja) * | 2002-11-21 | 2006-03-16 | ジェノミディア株式会社 | 所望の機能的性質を有する核酸の単離方法およびそのためのキット |
JP2004289816A (ja) * | 2003-03-06 | 2004-10-14 | Matsushita Electric Ind Co Ltd | 遠隔制御装置、遠隔制御方法および被遠隔制御装置 |
US7871765B2 (en) | 2004-03-31 | 2011-01-18 | Genomidea Inc. | Composition having antitumor effect |
CA2562904C (en) | 2004-04-27 | 2013-07-02 | Wellstat Biologics Corporation | Cancer treatment using viruses and camptothecins |
WO2005120579A1 (ja) * | 2004-06-14 | 2005-12-22 | Ishihara Sangyo Kaisha, Ltd. | 膜融合活性のある不活性化ウイルスエンベロープの凍結乾燥組成物 |
KR20080039344A (ko) * | 2005-07-14 | 2008-05-07 | 웰스테트 바이올로직스 코포레이션 | 바이러스, 플루오로피리미딘 및 캄토테신을 이용한 암치료방법 |
WO2007089780A2 (en) * | 2006-01-30 | 2007-08-09 | Licentia, Ltd. | Bmx/etk tyrosine kinase gene therapy materials and methods |
US20090053790A1 (en) * | 2006-01-31 | 2009-02-26 | Ishihara Sangyo Kaisha, Ltd. | Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell |
JP2008308440A (ja) * | 2007-06-14 | 2008-12-25 | Genomidea Inc | 癌治療用薬剤送達ビヒクルおよびその製造方法ならびにそれを用いた製剤 |
EP2345415B1 (en) * | 2008-09-16 | 2015-01-21 | GenomIdea Inc. | Therapeutic/prophylactic agent for prostate cancer |
EP2351574B1 (en) | 2008-10-10 | 2016-08-24 | Kringle Pharma, Inc. | Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue |
EP4089169A1 (en) | 2009-10-12 | 2022-11-16 | Larry J. Smith | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
JP4653242B1 (ja) | 2010-02-12 | 2011-03-16 | ナノキャリア株式会社 | 粒子状医薬組成物 |
US20130039943A1 (en) * | 2010-05-03 | 2013-02-14 | Bruno Rene Andre | Novel method |
CN103941924B (zh) * | 2014-04-25 | 2016-09-14 | 锐达互动科技股份有限公司 | 一种实现红外光编解码的互动投影方法 |
US11166995B2 (en) | 2016-11-01 | 2021-11-09 | Osaka University | Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor |
EP3544497A4 (en) * | 2016-11-22 | 2020-08-05 | Cedars-Sinai Medical Center | NOVEL TRANSFECTION AND ACTIVE SUBSTANCE RELEASE DEVICE |
US20190358276A1 (en) | 2016-12-06 | 2019-11-28 | Osaka University | Novel therapeutic agent for prionoid diseases |
EP4215214A1 (en) | 2020-09-16 | 2023-07-26 | Osaka University | Cancer therapeutic agent, immunostimulant and screening method for anticancer substance |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0005476B1 (de) * | 1978-05-17 | 1981-12-30 | Dr. Karl Thomae GmbH | Verfahren zur Herstellung von Humaninterferon |
CA1282721C (en) * | 1984-06-04 | 1991-04-09 | Bernard Roizman | Herpes simplex virus as a vector |
JP3414395B2 (ja) | 1990-10-19 | 2003-06-09 | ユニバーシティー オブ フロリダ | 人工的に製造したウィルスのエンベロープ |
US5879685A (en) * | 1991-05-08 | 1999-03-09 | Schweiz, Serum- & Impfinstitut Bern | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
US6268213B1 (en) * | 1992-06-03 | 2001-07-31 | Richard Jude Samulski | Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
US5244635A (en) * | 1992-06-19 | 1993-09-14 | Cirrus Diagnostics, Inc. | Centrifuge vessel with coaxial waste chamber having cap to prevent waste fluid transfer from the chamber into the vessel |
US5578475A (en) * | 1993-07-12 | 1996-11-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
FR2713657B1 (fr) * | 1993-12-13 | 1996-03-01 | Transgene Sa | Nouveaux vecteurs pour le traitement du sida. |
US5843459A (en) | 1996-01-19 | 1998-12-01 | Human Gene Therapy Research Institute | Differential inactivation of nucleic acids by chemical modification |
JP3744583B2 (ja) * | 1996-03-01 | 2006-02-15 | 株式会社ディナベック研究所 | 遺伝子導入用組成物及び該組成物を用いた遺伝子導入方法 |
US6451592B1 (en) * | 1996-04-05 | 2002-09-17 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
US5683866A (en) * | 1996-05-09 | 1997-11-04 | Sarkar; Debi P. | Process for producing a targeted gene |
US6183752B1 (en) * | 1997-02-05 | 2001-02-06 | Pasteur Merieux Serums Et Vaccins | Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
US6051428A (en) * | 1997-03-21 | 2000-04-18 | Sloan-Kettering Institute For Cancer Research | Rapid production of autologous tumor vaccines |
US5849561A (en) * | 1997-05-22 | 1998-12-15 | Cornell Research Foundation, Inc. | Method for the production of non-group C adenoviral vectors |
US6432925B1 (en) * | 1998-04-16 | 2002-08-13 | John Wayne Cancer Institute | RNA cancer vaccine and methods for its use |
US6472375B1 (en) * | 1998-04-16 | 2002-10-29 | John Wayne Cancer Institute | DNA vaccine and methods for its use |
EP1137771A2 (en) * | 1998-11-10 | 2001-10-04 | The Board Of Regents, The University Of Texas System | Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
AU769385C (en) * | 2000-02-02 | 2004-07-29 | Genomldea Inc. | Virus envelope vector for gene transfer |
US6509162B1 (en) * | 2000-02-29 | 2003-01-21 | Yale University | Methods for selectively modulating survivin apoptosis pathways |
-
2001
- 2001-02-02 AU AU30578/01A patent/AU769385C/en not_active Expired
- 2001-02-02 WO PCT/JP2001/000782 patent/WO2001057204A1/ja active IP Right Grant
- 2001-02-02 EP EP01902759A patent/EP1170363B1/en not_active Expired - Lifetime
- 2001-02-02 KR KR1020017012501A patent/KR100776475B1/ko active IP Right Grant
- 2001-02-02 CN CNB2004101002195A patent/CN100542614C/zh not_active Expired - Lifetime
- 2001-02-02 US US09/937,839 patent/US6913923B2/en not_active Expired - Lifetime
- 2001-02-02 KR KR1020077009410A patent/KR100847385B1/ko active IP Right Grant
- 2001-02-02 DE DE60131498T patent/DE60131498T8/de active Active
- 2001-02-02 CN CNB018005675A patent/CN100532559C/zh not_active Expired - Lifetime
- 2001-02-02 TW TW090102208A patent/TWI303663B/zh not_active IP Right Cessation
- 2001-02-02 CN CNA2008100016273A patent/CN101302536A/zh active Pending
- 2001-02-02 CA CA002369491A patent/CA2369491C/en not_active Expired - Lifetime
-
2002
- 2002-11-27 HK HK02108562.9A patent/HK1047449A1/zh unknown
-
2004
- 2004-04-14 US US10/824,757 patent/US7279333B2/en not_active Expired - Lifetime
-
2005
- 2005-05-10 US US11/126,770 patent/US7803621B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HK1047449A1 (zh) | 2003-02-21 |
DE60131498T8 (de) | 2009-01-29 |
EP1170363A1 (en) | 2002-01-09 |
KR20020004987A (ko) | 2002-01-16 |
KR100776475B1 (ko) | 2007-11-16 |
CA2369491A1 (en) | 2001-08-09 |
US7803621B2 (en) | 2010-09-28 |
KR100847385B1 (ko) | 2008-07-18 |
AU769385B2 (en) | 2004-01-22 |
US20040219674A1 (en) | 2004-11-04 |
WO2001057204A1 (fr) | 2001-08-09 |
AU3057801A (en) | 2001-08-14 |
EP1170363A4 (en) | 2002-06-12 |
US20030013195A1 (en) | 2003-01-16 |
CN1657103A (zh) | 2005-08-24 |
EP1170363B1 (en) | 2007-11-21 |
CN100532559C (zh) | 2009-08-26 |
CN100542614C (zh) | 2009-09-23 |
DE60131498T2 (de) | 2008-10-02 |
US7279333B2 (en) | 2007-10-09 |
CN101302536A (zh) | 2008-11-12 |
AU769385C (en) | 2004-07-29 |
TWI303663B (en) | 2008-12-01 |
CA2369491C (en) | 2008-09-02 |
US20050239188A1 (en) | 2005-10-27 |
US6913923B2 (en) | 2005-07-05 |
DE60131498D1 (de) | 2008-01-03 |
KR20070059182A (ko) | 2007-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1365388A (zh) | 用于基因转移的病毒包膜载体 | |
US10202581B2 (en) | Methods and compositions for production of vaccinia virus | |
CN1059705C (zh) | 高等真核细胞中引入核酸复合物的组合物 | |
Sasnauskas et al. | Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae | |
ES2345606T3 (es) | Multiplicacion de virus en un cultivo celular. | |
JP5284780B2 (ja) | 癌の治療のための単純ヘルペスウイルス2型変異体の使用 | |
CN1279165C (zh) | 流感疫苗组合物 | |
JP4447054B2 (ja) | 細胞培養におけるインフルエンザウイルスの複製の方法、および本方法によって入手可能なインフルエンザウイルス | |
CN1360638A (zh) | 用编码腺病毒e1蛋白的序列在人体细胞中生产重组蛋白 | |
JP2004331673A (ja) | インフルエンザウイルスの複製のための動物細胞および方法 | |
CN1132791A (zh) | 转染动物细胞的重组dna病毒载体 | |
WO2012048093A2 (en) | Enhanced msc preparations | |
CN1283233A (zh) | 突变型loxP序列及其应用 | |
CN109790521A (zh) | 在基本上无血清的培养基中大规模产生细小病毒h-1的优化的方法 | |
CN111040024A (zh) | 4型禽腺病毒基因工程疫苗及其制备方法与应用 | |
JP3942362B2 (ja) | 遺伝子導入のためのウイルスエンベロープベクター | |
CN1697879A (zh) | 利用病毒包膜导入生物分子的方法及其组合物和体系 | |
Tsao et al. | Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells | |
JP2015535687A (ja) | 新規mvaウイルス及びその使用 | |
JP2022539511A (ja) | ウイルスの生産方法及び採取用溶液組成物 | |
JP7406377B2 (ja) | 安定なウイルス含有組成物 | |
CN113038970A (zh) | 用于治疗进行性家族性肝内胆汁淤积症3型(pfic3)的密码子优化的转基因 | |
CN1642560A (zh) | 透明质酸介导的腺病毒转导 | |
AU2009201629A1 (en) | Production of ALVAC on avian embryonic stem cells | |
Krauzewicz et al. | Polyoma and papilloma virus vectors for cancer gene therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1047449 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: GENOMIDEA INC. Free format text: FORMER OWNER: ANGES MG INC. Effective date: 20140930 Free format text: FORMER OWNER: YASUSHI KANEDA Effective date: 20140930 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140930 Address after: Osaka Japan Patentee after: Keno Biological Engineering (pharmaceutical) Company Address before: Osaka Japan Patentee before: Anges Mg Co., Ltd. Patentee before: Yasushi Kaneda |
|
CX01 | Expiry of patent term |
Granted publication date: 20090826 |
|
CX01 | Expiry of patent term |